Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients

Condition:   Chronic Hepatitis Interventions:   Drug: Group A, TDF;   Drug: Group B:TDF then TDF and Peginterferon alfa-2a;   Drug: Group C:TDF and Peginterferon alfa-2a then TDF Sponsor:   Ruijin Hospital Active, not recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials